TOP1 and neoplasm: Anti-miR-21 induced decrease in cancer proliferation was exposed by the introduction of topotecan which is a chemotherapeutic drug, this is an inhibitor of “DNA topoisomerase I”.29 Such novel events highly recommends that clampdown of the oncogenic miR-21 could alert or sensitize tumor cells to anti-cancer therapy.